kpcczКомплексные проблемы сердечно-сосудистых заболеванийComplex Issues of Cardiovascular Diseases2306-12782587-9537Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”10.17802/2306-1278-2026-15-1-97-108kpccz-1663Research ArticleАНАЛИТИЧЕСКИЙ ОБЗОР. Внутренние болезниREVIEWS. Internal medicineСИНДРОМ ОБСТРУКТИВНОГО АПНОЭ СНА И ХРОНИЧЕСКАЯ БОЛЕЗНЬ ПОЧЕК: АНАЛИТИЧЕСКИЙ ОБЗОРOBSTRUCTIVE SLEEP APNEA AND CHRONIC KIDNEY DISEASE: AN ANALYTICAL REVIEWhttps://orcid.org/0000-0003-3554-0659ЕвлампиеваЛариса ГеннадьевнаEvlampievaLarisa G.

кандидат медицинских наук младший научный сотрудник лаборатории инструментальной диагностики научного отдела инструментальных методов исследования Тюменского кардиологического научного центра – филиала федерального государственного бюджетного научного учреждения «Томский национальный исследовательский медицинский центр Российской академии наук», Тюмень, Российская Федерация

PhD, Junior Researcher at the Laboratory of Instrumental Diagnostics, Department of Instrumental Research Methods, Tyumen Cardiology Research Center, Branch of Tomsk National Research Medical Center, Tyumen, Russian Federation

evlampieva.l.g@gmail.comhttps://orcid.org/0000-0002-6297-7859ХарацВсеволод ЕвсеевичKharatsVsevolod E.

кандидат медицинских наук заведующий отделением хирургического лечения сложных нарушений ритма сердца и электрокардиостимуляции, старший научный сотрудник лаборатории инструментальной диагностики научного отдела инструментальных методов исследования Тюменского кардиологического научного центра – филиала федерального государственного бюджетного научного учреждения «Томский национальный исследовательский медицинский центр Российской академии наук», Тюмень, Российская Федерация

PhD, Head of the Department of Surgical Treatment of Complex Heart Rhythm Disorders and Pacing, Senior Researcher at the Laboratory of Instrumental Diagnostics, Department of Instrumental Research Methods, Tyumen Cardiological Research Center, Branch of Tomsk National Research Medical Center, Tyumen, Russian Federation

https://orcid.org/0000-0003-1436-8853ЯрославскаяЕлена ИльиничнаYaroslavskayaElena I.

доктор медицинских наук ведущий научный сотрудник, заведующая лаборатории инструментальной диагностики научного отдела инструментальных методов исследования Тюменского кардиологического научного центра – филиала Федерального государственного бюджетного научного учреждения «Томский национальный исследовательский медицинский центр Российской академии наук», Тюмень, Российская Федерация

PhD, Leading Researcher, Head of Laboratory of Instrumental Diagnostics, Department of Instrumental Research Methods, Tyumen Cardiological Research Center, Branch of Tomsk National Research Medical Center, Tyumen, Russian Federation

Тюменский кардиологический научный центр – филиал Федерального государственного бюджетного научного учреждения «Томский национальный исследовательский медицинский центр Российской академии наук»РоссияTyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of ScienceRussian Federation20262802202615197108Copyright © Евлампиева Л.Г., Харац В.Е., Ярославская Е.И., 20262026Евлампиева Л.Г., Харац В.Е., Ярославская Е.И.Evlampieva L.G., Kharats V.E., Yaroslavskaya E.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nii-kpssz.com/jour/article/view/1663Основные положения

Основные положения

Проанализированы и представлены данные отечественных и зарубежных источников о взаимосвязи синдрома обструктивного апноэ сна и хронической болезни почек. Показаны особенности клинических проявлений синдрома обструктивного апноэ сна у пациентов с хронической болезнью почек. Освещено протективное влияние СИПАП терапии на функцию почек.

 

 

Резюме

Резюме

Синдром обструктивного апноэ сна (СОАС) и хроническая болезнь почек (ХБП) – клинически значимые заболевания с высокой коморбидностью, потенцирующие риск развития сердечно-сосудистых осложнений. Распространенность этих патологических состояний прогрессивно растет. При этом проблема ассоциации СОАС и ХБП является недооцененной и достаточно актуальной. В обзорной статье представлены особенности клинического течения СОАС у пациентов с ХБП, а также основные патофизиологические механизмы, влияющие на взаимосвязь СОАС и ХБП. Показана роль СИПАП терапии (от англ. Continuous Positive Airway Pressure, CPAP – поддержание постоянного положительного давления в дыхательных путях) в снижении риска прогрессирования ХБП и развития осложнений.

Highlights

Highlights

The data of domestic and foreign sources on the relationship between obstructive sleep apnea syndrome and chronic kidney disease are analyzed and presented. The features of clinical manifestations of obstructive sleep apnea syndrome in patients with chronic kidney disease are shown. The protective effect of CPAP therapy on kidney function is highlighted.

 

 

Abstract

Abstract

Obstructive sleep apnea syndrome (OSA) and chronic kidney disease (CKD) are clinically significant diseases with high comorbidity, potentiating the risk of developing cardiovascular complications. The prevalence of these pathological conditions is progressively increasing. At the same time, the problem of association between OSA and CKD is underestimated and quite relevant. The review article presents the features of the clinical course of OSA in patients with CKD, as well as the main pathophysiological mechanisms influencing the relationship between OSA and CKD. The role of CPAP (Continuous Positive Airway Pressure, CPAP) therapy in reducing the risk of CKD progression and complications is shown.

Cиндром обструктивного апноэ снаХроническая болезнь почекСИПАП терапияObstructive sleep apneaChronic kidney diseaseCPAP therapyАвторы заявляют об отсутствии финансирования исследования.ReferencesJager K.J., Kovesdy C., Langham R., Rosenberg M., Jha V., Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019;34(11):1803-1805. doi: 10.1093/ndt/gfz174Jager K.J., Kovesdy C., Langham R., Rosenberg M., Jha V., Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019;34(11):1803-1805. doi: 10.1093/ndt/gfz174Hill N.R., Fatoba S.T., Oke J.L., Hirst J.A., O'Callaghan C.A., Lasserson D.S., Hobbs F.D. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;6;11(7):e0158765. doi: 10.1371/journal.pone.0158765Hill N.R., Fatoba S.T., Oke J.L., Hirst J.A., O'Callaghan C.A., Lasserson D.S., Hobbs F.D. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;6;11(7):e0158765. doi: 10.1371/journal.pone.0158765GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990—2017: a systematic analysis for the Global Burden of Disease 2017. Lancet. 2020;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990—2017: a systematic analysis for the Global Burden of Disease 2017. Lancet. 2020;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3Foreman K.J., Marquez N., Dolgert Foreman K.J., Marquez N., Dolgert A., Fukutaki K., Fullman N., McGaughey M., Pletcher M.A., Smith A.E., Tang K., Yuan C.W., Brown J.C., Friedman J., He J., Heuton K.R., Holmberg M., Patel D.J., Reidy P., Carter A., Cercy K., Chapin A., Douwes-Schultz D., Frank T., Goettsch F., Liu P.Y., Nandakumar V., Reitsma M.B., Reuter V., Sadat N., Sorensen R.J.D., Srinivasan V., Updike R.L., York H., Lopez A.D., Lozano R., Lim S.S., Mokdad A.H., Vollset S.E., Murray C.J.L. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5Foreman K.J., Marquez N., Dolgert Foreman K.J., Marquez N., Dolgert A., Fukutaki K., Fullman N., McGaughey M., Pletcher M.A., Smith A.E., Tang K., Yuan C.W., Brown J.C., Friedman J., He J., Heuton K.R., Holmberg M., Patel D.J., Reidy P., Carter A., Cercy K., Chapin A., Douwes-Schultz D., Frank T., Goettsch F., Liu P.Y., Nandakumar V., Reitsma M.B., Reuter V., Sadat N., Sorensen R.J.D., Srinivasan V., Updike R.L., York H., Lopez A.D., Lozano R., Lim S.S., Mokdad A.H., Vollset S.E., Murray C.J.L. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5Ржевская О.Н., Моисеева А.Ю., Эсауленко А.Н., Пинчук А.В., Алиджанова Х.Г. Хроническая болезнь почек и инфаркт миокарда. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2022;11(1):104–118. doi: 10.23934/2223-9022-2022-11-1-104-118Rzhevskaya O.N., Moiseyeva A.Y., Esaulenko A.N., Pinchuk A.V., Alidzhanova Kh.G. Chronic Kidney Disease and Myocardial Infarction. Russian Sklifosovsky Journal "Emergency Medical Care". 2022;11(1):104-118. (In Russ.) doi: 10.23934/2223-9022-2022-11-1-104-118Ткачева О.Н., Котовская Ю.В., Бобкова И.Н., Шутов А.М., Виллевальде С.В., Ефремова Е.В., Рунихина Н.К., Ерусланова К.А., Арутюнов Г.П., Батюшин М.М., Фролова Е.В. Хроническая болезнь почек у пациентов пожилого и старческого возраста. Согласованное мнение экспертов Российской ассоциации геронтологов и гериатров, Научного общества нефрологов России и Евразийской ассоциации терапевтов. Российский журнал гериатрической медицины. 2024;1(17):6–20. doi: 10.37586/2686-8636-1-2024-6-20Tkacheva O.N., Kotovskaya Yu. V., Bobkova I.N., Shutov A.M., Villevalde S.V., Efremova E.V., Runikhina N.K., Eruslanova K.A., Arutyunov G.P., Batyushin M.M. Frolova Е.V. Chronic Kidney Disease in Older Adults. Consensus Statement of Russian Association of Gerontologists and Geriatricians, Scientific Society of Nephrologists of Russia and Eurasian Association of Therapists. Russian Journal of Geriatric Medicine. 2024;1(17):6–20. (In Russ.) doi: 10.37586/2686-8636-1-2024-6-20Francis A., Harhay M.N., Ong A.C.M., Tummalapalli S. L., Ortiz A., Fogo A.B., Fliser D., Roy-Chaudhury P., Fontana M., Nangaku M., Wanner C., Malik C., Hradsky A., Adu D., Bavanandan S., Cusumano A., Sola L., Ulasi I , Jha V. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 2024;20:473–485. doi:10.1038/s41581-024-00820-6Francis A., Harhay M.N., Ong A.C.M., Tummalapalli S. L., Ortiz A., Fogo A.B., Fliser D., Roy-Chaudhury P., Fontana M., Nangaku M., Wanner C., Malik C., Hradsky A., Adu D., Bavanandan S., Cusumano A., Sola L., Ulasi I , Jha V. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 2024;20:473–485. doi:10.1038/s41581-024-00820-6Beaudin A.E., Raneri J.K., Ahmed S.B., Hirsch Allen A.J.M., Nocon A., Gomes T., Gakwaya S., Series F., Kimoff J., Skomro R.P., Ayas N.T., Hanly P.J. Risk of chronic kidney disease in patients with obstructive sleep apnea. Sleep. 2022;45(2):zsab267. doi: 10.1093/sleep/zsab267Beaudin A.E., Raneri J.K., Ahmed S.B., Hirsch Allen A.J.M., Nocon A., Gomes T., Gakwaya S., Series F., Kimoff J., Skomro R.P., Ayas N.T., Hanly P.J. Risk of chronic kidney disease in patients with obstructive sleep apnea. Sleep. 2022;45(2):zsab267. doi: 10.1093/sleep/zsab267Chou Y.T., Lee P.H., Yang C.T., Lin C.L., Veasey S., Chuang L.P., Lin S.W., Lin Y.S., Chen N.H. Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant. 2011;26(7):2244-2250. doi: 10.1093/ndt/gfq821Chou Y.T., Lee P.H., Yang C.T., Lin C.L., Veasey S., Chuang L.P., Lin S.W., Lin Y.S., Chen N.H. Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant. 2011;26(7):2244-2250. doi: 10.1093/ndt/gfq821Kanbay A., Buyukoglan H., Ozdogan N., Kaya E., Oymak F.S., Gulmez I., Demir R., Kokturk O., Covic A. Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease. Int Urol Nephrol. 2012;44(2):535-9. doi: 10.1007/s11255-011-9927-8Kanbay A., Buyukoglan H., Ozdogan N., Kaya E., Oymak F.S., Gulmez I., Demir R., Kokturk O., Covic A. Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease. Int Urol Nephrol. 2012;44(2):535-9. doi: 10.1007/s11255-011-9927-8Benjafield A.V., Ayas N.T., Eastwood P.R., Heinzer R., Ip M.S.M., Morrell M.J., Nunez C.M., Patel S.R., Penzel T., Pépin J.L., Peppard P.E., Sinha S., Tufik S., Valentine K., Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5Benjafield A.V., Ayas N.T., Eastwood P.R., Heinzer R., Ip M.S.M., Morrell M.J., Nunez C.M., Patel S.R., Penzel T., Pépin J.L., Peppard P.E., Sinha S., Tufik S., Valentine K., Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5Khokhrina A., Andreeva E., Degryse J.M. The prevalence of sleep-disordered breathing in Northwest Russia: The ARKHsleep study. Chron Respir Dis. 2020;17:1479973120928103. doi: 10.1177/1479973120928103Khokhrina A., Andreeva E., Degryse J.M. The prevalence of sleep-disordered breathing in Northwest Russia: The ARKHsleep study. Chron Respir Dis. 2020;17:1479973120928103. doi: 10.1177/1479973120928103Pisano A., Zoccali C., Bolignano D., D'Arrigo G., Mallamaci F. Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis. Clin Kidney J. 2023;17(1):sfad179. doi: 10.1093/ckj/sfad179Pisano A., Zoccali C., Bolignano D., D'Arrigo G., Mallamaci F. Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis. Clin Kidney J. 2023;17(1):sfad179. doi: 10.1093/ckj/sfad179Kuhlmann U., Becker H.F., Birkhahn M., Peter J.H., von Wichert P., Schütterle S., Lange H. Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol. 2000;53(6):460-6.Kuhlmann U., Becker H.F., Birkhahn M., Peter J.H., von Wichert P., Schütterle S., Lange H. Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol. 2000;53(6):460-6.Lavoie M.R., Patel J.A., Camacho M. Nocturnal dialysis improves sleep apnea more than daytime dialysis: a meta-analysis of crossover studies. Sleep Medicine. 2019;64:37-42. doi: 10.1016/j.sleep.2019.06.005Lavoie M.R., Patel J.A., Camacho M. Nocturnal dialysis improves sleep apnea more than daytime dialysis: a meta-analysis of crossover studies. Sleep Medicine. 2019;64:37-42. doi: 10.1016/j.sleep.2019.06.005Hui M., Li Y., Ye J., Zhuang Z., Wang W. Obstructive sleep apnea-hypopnea syndrome (OSAHS) comorbid with diabetes rather than OSAHS alone serves an independent risk factor for chronic kidney disease (CKD). Ann Palliat Med 2020;9(3):858-869. doi: 10.21037/apm.2020.03.21Hui M., Li Y., Ye J., Zhuang Z., Wang W. Obstructive sleep apnea-hypopnea syndrome (OSAHS) comorbid with diabetes rather than OSAHS alone serves an independent risk factor for chronic kidney disease (CKD). Ann Palliat Med 2020;9(3):858-869. doi: 10.21037/apm.2020.03.21Beaudin A.E., Raneri J.K., Ahmed S.B., Hirsch Allen AJM., Nocon A., Gomes T., Gakwaya S., Series F., Kimoff J., Skomro R.P., Ayas N.T., Hanly P.J. Risk of chronic kidney disease in patients with obstructive sleep apnea. Sleep. 2022;45(2):zsab267. doi: 10.1093/sleep/zsab267Beaudin A.E., Raneri J.K., Ahmed S.B., Hirsch Allen AJM., Nocon A., Gomes T., Gakwaya S., Series F., Kimoff J., Skomro R.P., Ayas N.T., Hanly P.J. Risk of chronic kidney disease in patients with obstructive sleep apnea. Sleep. 2022;45(2):zsab267. doi: 10.1093/sleep/zsab267Lin Y.S., Liu P.H., Lin S.W., Chuang L.P., Ho W.J., Chou Y.T., Juan K.C., Lo M.T., Chu P.H., Chen N.H. Simple obstructive sleep apnea patients without hypertension or diabetes accelerate kidney dysfunction: a population follow-up cohort study from Taiwan. Sleep Breath. 2017;21(1):85-91. doi: 10.1007/s11325-016-1376-2Lin Y.S., Liu P.H., Lin S.W., Chuang L.P., Ho W.J., Chou Y.T., Juan K.C., Lo M.T., Chu P.H., Chen N.H. Simple obstructive sleep apnea patients without hypertension or diabetes accelerate kidney dysfunction: a population follow-up cohort study from Taiwan. Sleep Breath. 2017;21(1):85-91. doi: 10.1007/s11325-016-1376-2Liu T., Zhan Y., Wang Y., Li Q., Mao H. Obstructive sleep apnea syndrome and risk of renal impairment: a systematic review and meta-analysis with trial sequential analysis. Sleep Breath. 2021;25(1):17-27. doi: 10.1007/s11325-020-02090-5Liu T., Zhan Y., Wang Y., Li Q., Mao H. Obstructive sleep apnea syndrome and risk of renal impairment: a systematic review and meta-analysis with trial sequential analysis. Sleep Breath. 2021;25(1):17-27. doi: 10.1007/s11325-020-02090-5Yayan J., Rasche K., Vlachou A. Obstructive Sleep Apnea and Chronic Kidney Disease. Adv Exp Med Biol. 2017;1022:11-18. doi: 10.1007/5584_2017_35Yayan J., Rasche K., Vlachou A. Obstructive Sleep Apnea and Chronic Kidney Disease. Adv Exp Med Biol. 2017;1022:11-18. doi: 10.1007/5584_2017_35Евлампиева Л.Г., Харац В.Е., Гуськова О.А., Сергейчик О.И., Широков Н.Е., Сталлингс А.Д., Горбатенко Е.А., Ярославская Е.И. Прогнозирование приверженности СИПАП-терапии у пациентов кардиологического профиля. Комплексные проблемы сердечно-сосудистых заболеваний. 2024;13(3):130-143. doi: 10.17802/2306-1278-2024-13-3-130-143Evlampieva L.G., Kharats V.E., Guskova O.A., Sergeichik O.I., Shirokov N.E., Stallings A.D., Gorbatenko E.A., Yaroslavskaya E.I. Prediction of adherence to CPAP therapy in cardiac patients. Complex Issues of Cardiovascular Diseases. 2024;13(3):130-143. (In Russ.) doi: 10.17802/2306-1278-2024-13-3-130-143Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., Jafar T.H., Heerspink H.J., Mann J.F., Matsushita K., Wen C.P. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339-52. doi: 10.1016/S0140-6736(13)60595-4Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., Jafar T.H., Heerspink H.J., Mann J.F., Matsushita K., Wen C.P. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339-52. doi: 10.1016/S0140-6736(13)60595-4Cozzolino M., Mangano M., Stucchi A., Ciceri P., Conte F., Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174Cozzolino M., Mangano M., Stucchi A., Ciceri P., Conte F., Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174Watanabe Y., Tanaka A., Furuhashi K., Saito S., Maruyama S. Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea Syndrome. Front Med (Lausanne). 2022;9:899359. doi: 10.3389/fmed.2022.899359Watanabe Y., Tanaka A., Furuhashi K., Saito S., Maruyama S. Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea Syndrome. Front Med (Lausanne). 2022;9:899359. doi: 10.3389/fmed.2022.899359Jamwal J., Qadri S.M., Siraj F., Shah S. Prevalence of obstructive sleep apnea in patients with chronic kidney disease: a hospital-based study. Sleep Breath. 2023;27(5):1703-1708. doi: 10.1007/s11325-022-02764-2Jamwal J., Qadri S.M., Siraj F., Shah S. Prevalence of obstructive sleep apnea in patients with chronic kidney disease: a hospital-based study. Sleep Breath. 2023;27(5):1703-1708. doi: 10.1007/s11325-022-02764-2Jhamb M., Ran X., Abdalla H., Roumelioti M.E., Hou S., Davis H., Patel S.R., Yabes J., Unruh M. Association of Sleep Apnea with Mortality in Patients with Advanced Kidney Disease. Clin J Am Soc Nephrol. 2020;15(2):182-190. doi: 10.2215/CJN.07880719Jhamb M., Ran X., Abdalla H., Roumelioti M.E., Hou S., Davis H., Patel S.R., Yabes J., Unruh M. Association of Sleep Apnea with Mortality in Patients with Advanced Kidney Disease. Clin J Am Soc Nephrol. 2020;15(2):182-190. doi: 10.2215/CJN.07880719Berry R.B., Budhiraja R., Gottlieb D.J., Gozal D., Iber C., Kapur V.K., Marcus C.L., Mehra R., Parthasarathy S., Quan S.F., Redline S., Strohl K.P., Davidson Ward S.L., Tangredi M.M. American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597-619. doi: 10.5664/jcsm.2172Berry R.B., Budhiraja R., Gottlieb D.J., Gozal D., Iber C., Kapur V.K., Marcus C.L., Mehra R., Parthasarathy S., Quan S.F., Redline S., Strohl K.P., Davidson Ward S.L., Tangredi M.M. American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597-619. doi: 10.5664/jcsm.2172Бузунов Р.В., Пальман А.Д., Мельников А.Ю., Авербух В.М., Мадаева И.М., Куликов А.Н. Диагностика и лечение синдрома обструктивного апноэ сна у взрослых. Рекомендации Российского общества сомнологов. Эффективная фармакотерапия. Неврология Спецвыпуск «Сон и его расстройства – 6». 2018;35:34-45.Buzunov R.V., Palman A.D., Melnikov A.Yu., Averbukh V.M., Madayeva I.M., Kulikov A.N. Diagnostics and Treatment of Obstructive Sleep Apnea Syndrome in Adults. Recommendations of the Russian Society of Sleep Medicine. Effective pharmacotherapy. Neurology Special issue "Sleep and its disorders - 6". 2018;35:34-45. (In Russ.).Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018Sircu V., Colesnic S.I., Covantsev S., Corlateanu O., Sukhotko A., Popovici C., Corlateanu A. The Burden of Comorbidities in Obstructive Sleep Apnea and the Pathophysiologic Mechanisms and Effects of CPAP. Clocks Sleep. 2023; 5(2):333-349. doi: 10.3390/clockssleep5020025Sircu V., Colesnic S.I., Covantsev S., Corlateanu O., Sukhotko A., Popovici C., Corlateanu A. The Burden of Comorbidities in Obstructive Sleep Apnea and the Pathophysiologic Mechanisms and Effects of CPAP. Clocks Sleep. 2023; 5(2):333-349. doi: 10.3390/clockssleep5020025Ефремова Е.В., Шутов А.М., Серов В.А. Синдром обструктивного апноэ сна у больных пожилого и старческого возраста с хронической болезнью почек. Терапия. 2021;3:36-42. doi: 10.18565/therapy.2021.3.36-42Efremova E.V., Shutov A.M., Serov V.A. Obstructive sleep apnea syndrome in elderly and senile patients with chronic kidney disease. Therapy. 2021;3:36-42. (In Russ.) doi: 10.18565/therapy.2021.3.36-42Somkearti P., Chattakul P., Khamsai S., Limpawattana P., Chindaprasirt J., Chotmongkol V., Sawanyawisuth K. Predictors of chronic kidney disease in obstructive sleep apnea patients. Multidiscip Respir Med. 2020;15(1):470. doi: 10.4081/mrm.2020.470Somkearti P., Chattakul P., Khamsai S., Limpawattana P., Chindaprasirt J., Chotmongkol V., Sawanyawisuth K. Predictors of chronic kidney disease in obstructive sleep apnea patients. Multidiscip Respir Med. 2020;15(1):470. doi: 10.4081/mrm.2020.470Бормина С.О., Коростовцева Л.С., Бочкарев М.В., Свиряев Ю.В., Конради А.О., Тихоненко В.М. Полифункциональный мониторинг: возможна ли одновременная оценка артериального давления и нарушений дыхания во сне? Кардиология. 2020;60(1):10–15. doi: 10.18087/cardio.2020.1.n482Bormina S.O., Korostovtseva L.S., Bochkarev M.V., Sviryaev Y.V., Konradi A.O., Tikhonenko V.M. Multifunctional Monitoring: is it Possible to Simultaneously Evaluate Blood Pressure and Sleep-Disordered Breathing? Kardiologiia. 2020;60(1):10–15. (In Russ.) doi: 10.18087/cardio.2020.1.n482Кузьмин О.Б., Жежа В.В., Белянин В.В., Бучнева Н.В. Влияние хронической болезни почек на формирование диастолической дисфункции сердца у больных ХСН с сохраненной ФВ. Кардиология. 2018;58(S4):37-45. doi: 10.18087/cardio.2451Kuzmin O.B., Zhezha V.V., Belyanin V.V., Buchneva N.V. Effect of chronic kidney disease on the formation of diastolic heart dysfunction in heart failure patients with preserved ejection fraction. Kardiologiia. 2018;58(4S):37-45. (In Russ.) doi: 10.18087/cardio.2451Крупичка К.С., Агальцов М.В., Береговская С.А., Мясников Р.П., Драпкина О.М. Нарушения дыхания во сне у пациентов с хронической сердечной недостаточностью со сниженной и умеренно сниженной фракцией выброса левого желудочка: представленность основных типов и их зависимость от этиологии хронической сердечной недостаточности. Российский кардиологический журнал. 2023;28(1S):5261. doi: 10.15829/1560-4071-2023-5261Krupichka K.S., Agaltsov M.V., Beregovskaya S.A., Myasnikov R.P., Drapkina O.M. Sleep-related breathing disorders in patients with heart failure with reduced and mildly reduced ejection fraction: main types and their dependence on heart failure etiology. Russian Journal of Cardiology. 2023;28(1S):5261. (In Russ.) doi: 10.15829/1560-4071-2023-5261Алиджанова Х.Г., Ржевская О.Н., Сагиров М.А., Газарян Г.А. Прогностическое значение хронической болезни почек у больных с острым коронарным синдромом. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2017; 6(2): 132-139. doi: 10.23934/2223-9022-2017-6-2132-139Alidzhanova K.G., Rzhevskaya O.N., Sagirov M.A., Gazaryan G.A. Prognostic importance of chronic kidney disease in patients with acute coronary syndrome. Russian Sklifosovsky Journal «Emergency Medical Care». 2017;6(2):132-139. (In Russ.) doi: 10.23934/2223-9022-2017-6-2132-139Осипова О.А., Гостева Е.В., Жернакова Н.И., Шепель Р.Н., Пономаренко Е.Н., Иншакова К.Ю., Драпкина О.М. Особенности суточного профиля артериального давления и системного воспаления у больных стабильной ишемической болезнью сердца с обструктивным апноэ сна. Кардиоваскулярная терапия и профилактика. 2023;22(9):3705. doi: 10.15829/1728-8800-2023-3705Osipova O.A., Gosteva E.V., Zhernakova N.I., Shepel R.V., Ponomarenko T.N., Inshakova K.Yu., Drapkina O.M. 24-hour blood pressure profile and systemic inflammation in patients with stable coronary artery disease with obstructive sleep apnea. Cardiovascular Therapy and Prevention. 2023;22(9):3705. (In Russ.) doi: 10.15829/1728-8800-2023-3705Zamarrón E., Jaureguizar A., García-Sánchez A., Díaz-Cambriles T., Alonso-Fernández A., Lores V., Mediano S.A.O., Rodriguez-Rodriguez P., Cabello Pelegrin S., Morales-Ruiz E., Ramirez-Prieto M.T., Isabel Valiente-Diae M., Gomez-Garcia T., Gargia-Rio F., Spanish Sleep N. Obstructive sleep apnea is associated with impaired renal function in patients with diabetic kidney disease. Sci Rep. 2021;11(1):5675. doi: 10.1038/s41598-021-85023-wZamarrón E., Jaureguizar A., García-Sánchez A., Díaz-Cambriles T., Alonso-Fernández A., Lores V., Mediano S.A.O., Rodriguez-Rodriguez P., Cabello Pelegrin S., Morales-Ruiz E., Ramirez-Prieto M.T., Isabel Valiente-Diae M., Gomez-Garcia T., Gargia-Rio F., Spanish Sleep N. Obstructive sleep apnea is associated with impaired renal function in patients with diabetic kidney disease. Sci Rep. 2021;11(1):5675. doi: 10.1038/s41598-021-85023-wHui M, Li Y, Ye J, Zhuang Z, Wang W. Obstructive sleep apnea-hypopnea syndrome (OSAHS) comorbid with diabetes rather than OSAHS alone serves an independent risk factor for chronic kidney disease (CKD). Ann Palliat Med. 2020;9(3):858-869. doi: 10.21037/apm.2020.03.21Hui M, Li Y, Ye J, Zhuang Z, Wang W. Obstructive sleep apnea-hypopnea syndrome (OSAHS) comorbid with diabetes rather than OSAHS alone serves an independent risk factor for chronic kidney disease (CKD). Ann Palliat Med. 2020;9(3):858-869. doi: 10.21037/apm.2020.03.21Yayan J., Rasche K. A Systematic Review of Risk factors for Sleep Apnea. Prev Med Rep. 2024;42:102750. doi: 10.1016/j.pmedr.2024.102750Yayan J., Rasche K. A Systematic Review of Risk factors for Sleep Apnea. Prev Med Rep. 2024;42:102750. doi: 10.1016/j.pmedr.2024.102750Yin T., Chen Y., Tang L., Yuan H., Zeng X., Fu P. Relationship between modifiable lifestyle factors and chronic kidney disease: a bibliometric analysis of top-cited publications from 2011 to 2020. BMC Nephrol. 2022;23(1):120. doi: 10.1186/s12882-022-02745-3Yin T., Chen Y., Tang L., Yuan H., Zeng X., Fu P. Relationship between modifiable lifestyle factors and chronic kidney disease: a bibliometric analysis of top-cited publications from 2011 to 2020. BMC Nephrol. 2022;23(1):120. doi: 10.1186/s12882-022-02745-3Hwu D.W., Lin K.D., Lin K.C., Lee Y.J., Chang Y.H. The association of obstructive sleep apnea and renal outcomes-a systematic review and meta-analysis. BMC Nephrology. 2017;18(1):313. doi: 10.1186/s12882-017-0731-2Hwu D.W., Lin K.D., Lin K.C., Lee Y.J., Chang Y.H. The association of obstructive sleep apnea and renal outcomes-a systematic review and meta-analysis. BMC Nephrology. 2017;18(1):313. doi: 10.1186/s12882-017-0731-2Adams R.J., Appleton S.L., Vakulin A., Hanly P.J., McDonald S.P., Martin S.A., Lang C.J., Taylor A.W., McEvoy R.D., Antic N.A., Catcheside P.G., Vincent A.D., Wittert G.A. Chronic Kidney Disease and Sleep Apnea Association of Kidney Disease With Obstructive Sleep Apnea in a Population Study of Men. Sleep. 2017;40(1). doi: 10.1093/sleep/zsw015Adams R.J., Appleton S.L., Vakulin A., Hanly P.J., McDonald S.P., Martin S.A., Lang C.J., Taylor A.W., McEvoy R.D., Antic N.A., Catcheside P.G., Vincent A.D., Wittert G.A. Chronic Kidney Disease and Sleep Apnea Association of Kidney Disease With Obstructive Sleep Apnea in a Population Study of Men. Sleep. 2017;40(1). doi: 10.1093/sleep/zsw015So J.Y., Warburton K.M., Rosen I.M. A Guide to Management of Sleepiness in ESKD. Am J Kidney Dis. 2020;75(5):782-792. doi: 10.1053/j.ajkd.2019.09.010So J.Y., Warburton K.M., Rosen I.M. A Guide to Management of Sleepiness in ESKD. Am J Kidney Dis. 2020;75(5):782-792. doi: 10.1053/j.ajkd.2019.09.010Koh J.H., Lim C.Y.J., Yam K.J.M., Yeo B.S.Y., Ng A.C.W., Loh S.R.H., Hsu P.P., Gooley J., Tan C.S., Toh S.T. Bidirectional association of sleep disorders with chronic kidney disease: a systematic review and meta-analysis. Clin Kidney J. 2024;17(11):sfae279. doi: 10.1093/ckj/sfae279Koh J.H., Lim C.Y.J., Yam K.J.M., Yeo B.S.Y., Ng A.C.W., Loh S.R.H., Hsu P.P., Gooley J., Tan C.S., Toh S.T. Bidirectional association of sleep disorders with chronic kidney disease: a systematic review and meta-analysis. Clin Kidney J. 2024;17(11):sfae279. doi: 10.1093/ckj/sfae279Theofilou P. Association of insomnia symptoms with kidney disease quality of life reported by patients on maintenance dialysis. Psychol Health Med. 2013;18(1):70-8. doi: 10.1080/13548506.2012.674144Theofilou P. Association of insomnia symptoms with kidney disease quality of life reported by patients on maintenance dialysis. Psychol Health Med. 2013;18(1):70-8. doi: 10.1080/13548506.2012.674144Maung S.C., El Sara A., Chapman C., Cohen D., Cukor D. Sleep disorders and chronic kidney disease. World J Nephrol. 2016;5(3):224-232. doi: 10.5527/wjn.v5.i3.224Maung S.C., El Sara A., Chapman C., Cohen D., Cukor D. Sleep disorders and chronic kidney disease. World J Nephrol. 2016;5(3):224-232. doi: 10.5527/wjn.v5.i3.224Nicholl D.D., Ahmed S.B., Loewen A.H., Hemmelgarn B.R., Sola D.Y., Beecroft J.M., Turin T.C., Hanly P.J. Clinical presentation of obstructive sleep apnea in patients with chronic kidney disease. J Clin Sleep Med. 2012;8(4):381-7. doi: 10.5664/jcsm.2028Nicholl D.D., Ahmed S.B., Loewen A.H., Hemmelgarn B.R., Sola D.Y., Beecroft J.M., Turin T.C., Hanly P.J. Clinical presentation of obstructive sleep apnea in patients with chronic kidney disease. J Clin Sleep Med. 2012;8(4):381-7. doi: 10.5664/jcsm.2028Parker K.P., Bliwise D.L., Bailey J.L., Rye D.B. Daytime sleepiness in stable hemodialysis patients. Am J Kidney Dis. 2003;41(2):394-402. doi: 10.1053/ajkd.2003.50049Parker K.P., Bliwise D.L., Bailey J.L., Rye D.B. Daytime sleepiness in stable hemodialysis patients. Am J Kidney Dis. 2003;41(2):394-402. doi: 10.1053/ajkd.2003.50049Jean G., Piperno D., François B., Charra B. Sleep apnea incidence in maintenance hemodialysis patients: influence of dialysate buffer. Nephron. 1995;71(2):138-42. doi: 10.1159/000188701Jean G., Piperno D., François B., Charra B. Sleep apnea incidence in maintenance hemodialysis patients: influence of dialysate buffer. Nephron. 1995;71(2):138-42. doi: 10.1159/000188701Pressman M., Benz R.L., Schleifer CR., Peterson D.D. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int. 1993;43(5):1134-9. doi: 10.1038/ki.1993.159Pressman M., Benz R.L., Schleifer CR., Peterson D.D. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int. 1993;43(5):1134-9. doi: 10.1038/ki.1993.159Beecroft J.M., Pierratos A., Hanly P.J. Clinical presentation of obstructive sleep apnea in patients with end-stage renal disease. J Clin Sleep Med. 2009;5(2):115-121.Beecroft J.M., Pierratos A., Hanly P.J. Clinical presentation of obstructive sleep apnea in patients with end-stage renal disease. J Clin Sleep Med. 2009;5(2):115-121.Abuvassin B., Sharma K., Ayas N.T. Laher I. Obstructive sleep apnea and kidney disease: a potential bidirectional relationship? J Clin Sleep Med. 2015;11(8):915–924. doi: 10.5664/jcsm.4946Abuvassin B., Sharma K., Ayas N.T. Laher I. Obstructive sleep apnea and kidney disease: a potential bidirectional relationship? J Clin Sleep Med. 2015;11(8):915–924. doi: 10.5664/jcsm.4946Оксенюк О.С., Калмыкова Ю.А., Смирнова О.Б., Пасечник Д.Г. Роль окислительного стресса в развитии хронической болезни почек и способы его оценки. Журнал фундаментальной медицины и биологии. 2016;1:15-24.Oksenyuk O.S., Kalmykova Yu.A., Smirnova O.B., Pasechnik D.G. The role of oxidative stress in the development of kidney diseases and methods of its assessment. Journal of Fundamental Medicine and Biology. 2016;1:15-24. (In Russ.).Кузьмин О.Б. Хроническая болезнь почек: механизмы развития и прогрессирования гипоксического гломерулосклероза и тубулоинтерстициального фиброза. Нефрология. 2015;19(4):6-16.Kuzmin O.B. Chronic kidney disease: mechanisms of hypoxic glomerulosclerosis and tubulointerstitial fibrosis development and progression. Nephrology (Saint-Petersburg). 2015;19(4):6-16. (In Russ.).Резник Е.В., Никитин И.Г. Кардиоренальный синдром у больных с сердечной недостаточностью как этап кардиоренального континуума (часть 2): прогностическое значение, профилактика и лечение. Архивъ внутренней медицины. 2019;9(2): 93-106. doi: 10.20514/2226-6704-2019-9-2-93-106Reznik E.V., Nikitin I.G. Cardiorenal syndrome in patients with heart failure as a stage of the cardiorenal continuum (part 2): prognosis, prevention and treatment. The Russian Archives of Internal Medicine. 2019;9(2):93-106. (In Russ.) doi: 10.20514/2226-6704-2019-9-2-93-106Зелвеян П.А., Дгерян Л.Г. Основные патофизиологические звенья поражения почек при синдроме обструктивного апноэ во сне. Терапевтический архив. 2014;86(6):100-105.Zelveian P.A., Dgerian L.G. The main pathophysiologigal mechanisms of kidney injury in obstructive sleep apnea syndrome. Therapeutic archive. 2014;86(6):100-105. (In Russ.).Драпкина О.М., Дуболазова Ю.В., Корнеева О.Н. Обструктивное апноэ сна как фактор риска сердечно-сосудистых заболеваний: лечить или не лечить? 2017;16(3):68-74. doi: 10.15829/1728-8800-2017-3-68-74Drapkina О.M., Dubolazova Yu.V., Korneeva О.N. Obstructive sleep apnea as cardiovascular risk factor: to treat or not? Cardiovascular Therapy and Prevention. 2017;16(3):68-74. (In Russ.) doi: 10.15829/1728-8800-2017-3-68-74Krieger J., Follenius M., Sforza E., Brandenberger G., Peter J.D. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond). 1991;80(5):443-9. doi: 10.1042/cs0800443Krieger J., Follenius M., Sforza E., Brandenberger G., Peter J.D. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond). 1991;80(5):443-9. doi: 10.1042/cs0800443Kara T., Narkiewicz K., Somers V.K. Chemoreflexes-physiology and clinical implications. Acta Physiol Scand. 2003;177(3):377-84. doi: 10.1046/j.1365-201X.2003.01083.xKara T., Narkiewicz K., Somers V.K. Chemoreflexes-physiology and clinical implications. Acta Physiol Scand. 2003;177(3):377-84. doi: 10.1046/j.1365-201X.2003.01083.xKimoff R.J. Upperairway myopathy is important in the pathophysiology of obstructive sleep apnea. J Clin Sleep Med. 2007;3(6):567-9.Kimoff R.J. Upperairway myopathy is important in the pathophysiology of obstructive sleep apnea. J Clin Sleep Med. 2007;3(6):567-9.Mavanur M., Sanders M., Unruh M. Sleep disordered breathing in patients with chronic kidney disease. Indian J Med Res. 2010;131:277-84.Mavanur M., Sanders M., Unruh M. Sleep disordered breathing in patients with chronic kidney disease. Indian J Med Res. 2010;131:277-84.Puckrin R., Iqbal S., Zidulka A., Vasilevsky M., Barre P. Renoprotective effects of continuous positive airway pressure in chronic kidney disease patients with sleep apnea. Int Urol Nephrol. 2015;47(11):1839-45. doi: 10.1007/s11255-015-1113-yPuckrin R., Iqbal S., Zidulka A., Vasilevsky M., Barre P. Renoprotective effects of continuous positive airway pressure in chronic kidney disease patients with sleep apnea. Int Urol Nephrol. 2015;47(11):1839-45. doi: 10.1007/s11255-015-1113-yVoulgaris A., Marrone O., Bonsignore M.R., Steiropoulos P. Chronic kidney disease in patients with obstructive sleep apnea. A narrative review. Sleep Med Rev. 2019;47:74-89. doi: 10.1016/j.smrv.2019.07.001Voulgaris A., Marrone O., Bonsignore M.R., Steiropoulos P. Chronic kidney disease in patients with obstructive sleep apnea. A narrative review. Sleep Med Rev. 2019;47:74-89. doi: 10.1016/j.smrv.2019.07.001Li X., Liu C., Zhang H., Zhang J., Zhao M., Sun D., Xia M., Han M. Effect of 12-month nasal continuous positive airway pressure therapy for obstructive sleep apnea on progression of chronic kidney disease. Medicine (Baltimore). 2019;98(8):e14545. doi: 10.1097/MD.0000000000014545Li X., Liu C., Zhang H., Zhang J., Zhao M., Sun D., Xia M., Han M. Effect of 12-month nasal continuous positive airway pressure therapy for obstructive sleep apnea on progression of chronic kidney disease. Medicine (Baltimore). 2019;98(8):e14545. doi: 10.1097/MD.0000000000014545Parmaksız E., Torun Parmaksız E. Reversibility of microalbuminuria with continuous positive airway pressure treatment in obstructive sleep apnea syndrome. Int Urol Nephrol. 2020;52(9):1719-1724. doi: 10.1007/s11255-020-02519-6Parmaksız E., Torun Parmaksız E. Reversibility of microalbuminuria with continuous positive airway pressure treatment in obstructive sleep apnea syndrome. Int Urol Nephrol. 2020;52(9):1719-1724. doi: 10.1007/s11255-020-02519-6Perticone M., Maio R., Scarpino P.E., Mancuso L., Volpentesta M., Caroleo B., Suraci E., Sciacqua A., Sesti G., Perticone F. Continuous Positive Airway Pressure Improves Renal Function in Obese Patients With Obstructive Sleep Apnea Syndrome. Front Med (Lausanne). 2021;8:642086. doi: 10.3389/fmed.2021.642086Perticone M., Maio R., Scarpino P.E., Mancuso L., Volpentesta M., Caroleo B., Suraci E., Sciacqua A., Sesti G., Perticone F. Continuous Positive Airway Pressure Improves Renal Function in Obese Patients With Obstructive Sleep Apnea Syndrome. Front Med (Lausanne). 2021;8:642086. doi: 10.3389/fmed.2021.642086Chen R., Huang Z.W., Lin X.F., Lin J.F., Yang M.J. Effect of continuous positive airway pressure on albuminuria in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2022;26(1):279-285. doi: 10.1007/s11325-021-02393-1Chen R., Huang Z.W., Lin X.F., Lin J.F., Yang M.J. Effect of continuous positive airway pressure on albuminuria in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2022;26(1):279-285. doi: 10.1007/s11325-021-02393-1Стаценко М.Е., Талагаев С.В. Влияние вспомогательной вентиляции легких положительным давлением на суточный профиль артериального давления и функцию почек у больных с синдромом обструктивного апноэ сна и артериальной гипертонией. Вестник Волгоградского государственного медицинского университета. 2015;12(2):116-119.Statsenko M.E., Talagayev S.V. Effect of assisted ventilation with positive pressure on the daily blood pressure and renal function in patients with obstructive sleep apnea syndrome and hypertension. Journal of Volgograd State Medical University. 2015;12(2):116-119. (In Russ.).Pochetti P., Azzolina D., Ragnoli B., Tillio P.A., Cantaluppi V., Malerba M. Interrelationship among Obstructive Sleep Apnea, Renal Function and Survival: A Cohort Study. Int J Environ Res Public Health. 2020;17(14):4922. doi: 10.3390/ijerph17144922Pochetti P., Azzolina D., Ragnoli B., Tillio P.A., Cantaluppi V., Malerba M. Interrelationship among Obstructive Sleep Apnea, Renal Function and Survival: A Cohort Study. Int J Environ Res Public Health. 2020;17(14):4922. doi: 10.3390/ijerph17144922Nicholl D.D.M., Hanly J., Zalucky A.A., Handley G.B., Sola D.Y., Ahmed S.B. Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea. Sleep. 2021;44(5):zsaa228. doi: 10.1093/sleep/zsaa228Nicholl D.D.M., Hanly J., Zalucky A.A., Handley G.B., Sola D.Y., Ahmed S.B. Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea. Sleep. 2021;44(5):zsaa228. doi: 10.1093/sleep/zsaa228Hanly P.J., Ahmed S., Fjell C.D., Handley G.B., Sola D., Nicholl D., Zalucky A. Urine biomarkers of renal renin-angiotensin system activity: Exploratory analysis in humans with and without obstructive sleep apnea. Physiol Rep. 2020;8(6):e14376. doi: 10.14814/phy2.14376Hanly P.J., Ahmed S., Fjell C.D., Handley G.B., Sola D., Nicholl D., Zalucky A. Urine biomarkers of renal renin-angiotensin system activity: Exploratory analysis in humans with and without obstructive sleep apnea. Physiol Rep. 2020;8(6):e14376. doi: 10.14814/phy2.14376Zhang L., Huang X., Li X., Wu Q. Alterations in renal function in patients with obstructive sleep apnea syndrome and effects of continuous positive airway pressure. Chin Med J (Engl). 1997;110(12):915-8.Zhang L., Huang X., Li X., Wu Q. Alterations in renal function in patients with obstructive sleep apnea syndrome and effects of continuous positive airway pressure. Chin Med J (Engl). 1997;110(12):915-8.Jin F., Liu J., Zhang X., Cai W., Zhang Y., Zhang W., Yang J., Lu G., Zhang X. Effect of continuous positive airway pressure therapy on inflammatory cytokines and atherosclerosis in patients with obstructive sleep apnea syndrome. Mol Med Rep. 2017;16(5):6334-6339. doi: 10.3892/mmr.2017.7399Jin F., Liu J., Zhang X., Cai W., Zhang Y., Zhang W., Yang J., Lu G., Zhang X. Effect of continuous positive airway pressure therapy on inflammatory cytokines and atherosclerosis in patients with obstructive sleep apnea syndrome. Mol Med Rep. 2017;16(5):6334-6339. doi: 10.3892/mmr.2017.7399Li C., Zhang X.L., Liu H., Wang Z.G., Yin K.S. Association among plasma interleukin-18 levels, carotid intima- media thickness and severity of obstructive sleep apnea. Chin Med J (Engl). 2009;122(1):24-9Li C., Zhang X.L., Liu H., Wang Z.G., Yin K.S. Association among plasma interleukin-18 levels, carotid intima- media thickness and severity of obstructive sleep apnea. Chin Med J (Engl). 2009;122(1):24-9Петрищев Н.Н., Ачкасова В.В., Мнускина М.М., Смирнов А.В., Панина И.Ю., Румянцев А.Ш., Меншутина М.А. Реактивность сосудов микроциркуляторного русла кожи при дистантном холодовом воздействии и уровень эндотелина-1 при хронической болезни почек. Регионарное кровообращение и микроциркуляция. 2011;10(4):59-64. doi: 10.24884/1682-6655-2011-10-4-59-64Petrichshev N.N., Achkasova V.V., Mnuskina M.M., Smirnov A.V., Panina I.Yu., Rumyantsev A.Sh., Menshutina M.A. Reactivity of microcirculation skin vessels during the distant cold influence and concentration of endotelin-1 in chronic kidney disease. Regional blood circulation and microcirculation. 2011;10(4):59-64. (In Russ.) doi: 10.24884/1682-6655-2011-10-4-59-64Lin G., Chen Q., Huang J., Chen L., Lin T., Lin Q. Effect of continuous positive airway pressure on endothelin-1 in patients with obstructive sleep apnea: a meta-analysis. Eur Arch Otorhinolaryngol. 2019;276(3):623-630. doi: 10.1007/s00405-018-5225-8Lin G., Chen Q., Huang J., Chen L., Lin T., Lin Q. Effect of continuous positive airway pressure on endothelin-1 in patients with obstructive sleep apnea: a meta-analysis. Eur Arch Otorhinolaryngol. 2019;276(3):623-630. doi: 10.1007/s00405-018-5225-8Шахмалова М.Ш., Курумова К.О., Клефортова И.И., Ситкин И.И., Ильин А.В., Арбузова М.И., Горчаров Н.П., Кация Г.В., Александров А.А., Кухаренко С.С., Шестакова М.В., Дедов И.И. Факторы развития тубулоинтерстициального повреждения почек у больных с сахарным диабетом. Сахарный диабет. 2010;13(3):134-141. doi: 10.14341/2072-0351-5502Shakhmalova M.Sh., Kurumova K.O., Klefortova I.I., Sitkin I.I., Ilyin A.V., Arbuzova M.I., Gorcharov N.P., Katsiya G.V., Aleksandrov A.A., Kukharenko S.S., Shestakova M.V., Dedov I.I. Factors promoting development of renal tubulointerstitial lesions in patients with diabetes mellitus. Diabetes mellitus. 2010;13(3):134-141. (In Russ.) doi: 10.14341/2072-0351-5502Celik Y., Jelic S., Behboudi A. CPAP Reduces Circulating Vascular Endothelial Growth Factor Levels in Patients with Coronary Artery Disease and Obstructive Sleep Apnoea:The RICCADSA Trial. European Respiratory Journal. 2023;62(suppl 67):ОА3286. doi: 10.1183/13993003.congress-2023.OA3286Celik Y., Jelic S., Behboudi A. CPAP Reduces Circulating Vascular Endothelial Growth Factor Levels in Patients with Coronary Artery Disease and Obstructive Sleep Apnoea:The RICCADSA Trial. European Respiratory Journal. 2023;62(suppl 67):ОА3286. doi: 10.1183/13993003.congress-2023.OA3286Ip M.S., Lam B., Chan L.Y., Zheng L., Tsang K.W., Fung P.C., Lam W.K. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162(6):2166-71. doi: 10.1164/ajrccm.162.6.2002126Ip M.S., Lam B., Chan L.Y., Zheng L., Tsang K.W., Fung P.C., Lam W.K. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162(6):2166-71. doi: 10.1164/ajrccm.162.6.2002126Güngördü N., Börekçi Ş., Çulpan H.C., Coşkun E., Ayan F., Mutlu B. Effect of continuous positive airway pressure therapy on pro-brain natriuretic peptide, C-reactive protein, homocysteine, and cardiac marker in patients with obstructive sleep apnea. Thorac. Res. Pract. 2023;24(2):76-84. doi: 10.5152/ThoracResPract.2023.22130Güngördü N., Börekçi Ş., Çulpan H.C., Coşkun E., Ayan F., Mutlu B. Effect of continuous positive airway pressure therapy on pro-brain natriuretic peptide, C-reactive protein, homocysteine, and cardiac marker in patients with obstructive sleep apnea. Thorac. Res. Pract. 2023;24(2):76-84. doi: 10.5152/ThoracResPract.2023.22130Lin C.C. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur Respir J. 1994;7(11):2005-2010.Lin C.C. Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur Respir J. 1994;7(11):2005-2010.

The authors declare that there are no conflicts of interest present.